Le Lézard
Classified in: Health
Subjects: NPT, CHI, DEI

JSI to Implement New USAID Maternal, Newborn, and Child Nutrition Activity in Laos


BOSTON, Sept. 16, 2021 /PRNewswire/ -- JSI Research & Training Institute, Inc. has been selected to lead the new USAID Laos Maternal Child Health and Nutrition Activity. The 5-year, $35 million activity will support the Government of Lao People's Democratic Republic (Lao PDR) to design, manage, and monitor high-quality and integrated reproductive, maternal, newborn, child, and adolescent health and nutrition services.

This work strengthens local capacity to improve health outcomes while weaving gender equality throughout the approach.

The activity will strengthen local capacity, and use collaborative learning, adaptive management, and human-centered design to improve health and nutrition outcomes while weaving gender equality and social inclusion throughout the approach. JSI has more than 20 years of experience in Laos' health sector and will continue to build collaborative relationships with the government, community-based health systems, provincial health offices, village health volunteers, and communities to catalyze these changes.

We have helped improve the capacity of health systems in over 80 countries to deliver high-quality maternal, newborn, and child health services. JSI will join partners World Education, Inc. and PATH to implement this activity and develop local leadership and expertise to strengthen the communities and institutions of Laos PDR, ensuring measurable and lasting systems to improve health and nutrition outcomes for women and children at scale. For more information about this work, please contact Mark Kowalski.

John Snow, Inc., and nonprofit affiliate, JSI Research & Training Institute, are global public health consulting organizations dedicated to greater health equity and improving the health of individuals and communities, and to providing an environment where people of passion can pursue this cause.

Contact: 
Mary-Kathryn Aranda
[email protected]

SOURCE John Snow, Inc.


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: